Potential cardiotoxicity with the use of DuP-941: a case report.

Sheila Walsh(University of Ottawa), Lyall Higginson(University of Ottawa), Virginia M. Walley(University of Ottawa), John P. Veinot(University of Ottawa), S. Huan, L Chandra

PubMed

May 1, 1995

Cited by 5

Related Papers

Pathology of Acute and Chronic Coronary Stenting in Humans

|Circulation|1999|874

Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women

|JAMA|2002|576

2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology

|Cardiovascular Pathology|2011|528

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

|Circulation|1994|505

Anatomy of the Normal Left Atrial Appendage

|Circulation|1997|418